Peregrine Capital Management LLC Has $5.07 Million Stock Position in AdaptHealth Corp. $AHCO

Peregrine Capital Management LLC decreased its position in AdaptHealth Corp. (NASDAQ:AHCO) by 3.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 537,065 shares of the company’s stock after selling 17,954 shares during the period. Peregrine Capital Management LLC owned approximately 0.40% of AdaptHealth worth $5,065,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. AlphaQuest LLC grew its holdings in shares of AdaptHealth by 275.7% in the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after buying an additional 2,892 shares during the period. GAMMA Investing LLC boosted its stake in AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock worth $81,000 after purchasing an additional 4,758 shares during the period. Brooklyn Investment Group boosted its stake in AdaptHealth by 531.8% in the 1st quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock worth $82,000 after purchasing an additional 6,366 shares during the period. CWM LLC boosted its stake in AdaptHealth by 1,562.1% in the 2nd quarter. CWM LLC now owns 10,471 shares of the company’s stock worth $99,000 after purchasing an additional 9,841 shares during the period. Finally, Y Intercept Hong Kong Ltd acquired a new position in AdaptHealth in the 1st quarter worth $114,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Trading Up 0.6%

Shares of NASDAQ:AHCO opened at $9.47 on Wednesday. The company’s 50-day moving average price is $9.17 and its two-hundred day moving average price is $9.00. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.63. The stock has a market capitalization of $1.28 billion, a PE ratio of 17.54, a price-to-earnings-growth ratio of 1.16 and a beta of 1.61.

Analyst Ratings Changes

A number of brokerages recently weighed in on AHCO. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of AdaptHealth in a research note on Wednesday, October 8th. Wall Street Zen raised shares of AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 19th. Finally, Zacks Research lowered shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Five investment analysts have rated the stock with a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $13.40.

Insider Activity

In other news, Director David Solomon Williams III sold 8,200 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the sale, the director directly owned 50,045 shares of the company’s stock, valued at approximately $486,937.85. This represents a 14.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.55% of the company’s stock.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.